ArticleDrug delivery and translational research2018
Production and characterization of drug-loaded toroidal vortices from a novel ocular drug delivery device.
Article in Drug delivery and translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For the last several decades, the predominant method for delivering medicine to the surface of the eye has been the standard multiuse eye dropper. While being the most popular, this method has significant limitations. Recently, an effort has been made to explore the use of a directed toroidal vortex or "smoke ring" aerosol delivery system that may help overcome these limitations and enable delivery of precise amounts of formulation and drug to the ocular surface. Promising preliminary in vitro studies indicated dosing control, but the physical characteristics of the toriodal aerosol device performance and impaction forces related to patient comfort have yet to be established. Here, we experimentally investigate the mechanics and dynamics of these ocular aerosol vortices, including translational and rotational velocities, spatial droplet size distributions, and relative impaction forces in order to optimize the device performance and evaluate potential for clinical use. Maximal droplet velocity at various actuation forces was determined, and they were found to be all less than 6 m/s even at the highest actuation forces. Moreover, plume impaction forces were determined across a range of conditions and were all less than about 4.5 μN. Collectively, these studies showed that the physical and mechanical properties of the emitted drug-loaded vortices would be suitable for ocular administration.
Indexed as
Identifiers
29968231What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.